Reset Therapeutic
Latest round
- Series B
Last raised
- Feb 2016
Total raised
- $30M
Investors
- 1
About Reset Therapeutic
Reset Therapeutics specializes in developing therapeutic solutions aimed at addressing specific health challenges.Reset Therapeutics, founded in 2008, is based in San Francisco, US. The company focuses on developing novel therapeutic solutions and has completed 5 deals to date.90 mn.Reset Therapeutics offers innovative therapeutic solutions that target specific health conditions, enhancing treatment effectiveness. The company serves various sectors within the healthcare industry, focusing on personalized medicine.The revenue model of Reset Therapeutics is based on strategic partnerships and direct client transactions. Their business transactions include subscription-based services, where clients engage in long-term contracts for ongoing support and updates. They are targeting expansion into additional markets within North America and Europe by 2024 to broaden their reach.
Who invested in Reset Therapeutic
1 investor across 1 round
See all investors in Reset Therapeutic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 18, 2016
Amount
$30M
Investors
Questions about Reset Therapeutic
Who invested in Reset Therapeutic?
Reset Therapeutic has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reset Therapeutic raised?
Reset Therapeutic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Reset Therapeutic last raise money?
Reset Therapeutic's most recent round on record is a Series B, in Feb 2016.
What does Reset Therapeutic do?
Reset Therapeutics specializes in developing therapeutic solutions aimed at addressing specific health challenges.
Where is Reset Therapeutic headquartered?
Reset Therapeutic is headquartered in San Francisco, US.
Which VCs invest in companies like Reset Therapeutic?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Reset Therapeutic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Reset Therapeutic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.